Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis. Strijbis EMM, Mostert J, Comtois J, Salter A, et al. Neurology 2025;104:e210153.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Strijbis EMM, Mostert J, Comtois J, Salter A, et al. Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis. Neurology 2025;104:e210153.
PMID: 39960455